Mr. Grasman brings more than 20 years of financial leadership experience in the biotechnology industry. He most recently served as Chief Financial Officer at AltruBio, a clinical-stage private biotech company, from August 2021 to May 2025. During his tenure at AltruBio, Mr. Grasman led finance and operations and helped scale the company for global clinical studies.
Before that, Mr. Grasman served as Vice President, Finance and Operations at PACT Pharma, a clinical-stage private biotech company. Prior to joining PACT Pharma, Mr. Grasman served as Vice President, Finance at Intarcia Therapeutics and before that spent more than 10 years at Genentech.
Mr. Grasman earned a MSc in Applied Mathematics from Groningen University in the Netherlands and an MBA from Harvard Business School.
